Who is the manufacturer of METANEB?

Hill-Rom Services Pte, Ltd. filed the 510(k) submission for METANEB (K124032).

What is the FDA product code for METANEB?

NHJ. It is classified under 21 CFR 868.5905 as a Class 2 device in the Anesthesiology panel.

What is the regulatory pathway for METANEB?

510(k) clearance (submission type: Traditional).

What are the predicate devices for METANEB?

PowerNeb® CoMedica (K051964); IPV - Percussionaire Corp (K895485).

Who can help prepare an FDA 510(k) submission like METANEB?

Innolitics — a medical-device software consultancy — provides regulatory and engineering support for FDA 510(k) submissions. See https://innolitics.com/services/510ks/ or contact https://innolitics.com/contact.

METANEB

K124032 · Hill-Rom Services Pte, Ltd. · NHJ · Apr 25, 2013 · Anesthesiology

Device Facts

Record ID	K124032
Device Name	METANEB
Applicant	Hill-Rom Services Pte, Ltd.
Product Code	NHJ · Anesthesiology
Decision Date	Apr 25, 2013
Decision	SESE
Submission Type	Traditional
Regulation	21 CFR 868.5905
Device Class	Class 2
Attributes	Therapeutic, Pediatric

Intended Use

The MetaNeb® System is indicated for mobilization of secretions, lung expansion therapy, the treatment and prevention of pulmonary atelectasis, and also has the ability to provide supplemental oxygen when used with compressed oxygen. Patient population - Adult and Children > 2 years old Environments of use - Hospitals, sub-acute facilities, physician offices, and clinics.

Device Story

MetaNeb® is a pneumatically operated therapeutic device for airway clearance and lung expansion. Input: 50 psi oxygen source. Operation: Controller manages three modes—Aerosol (medicated aerosol delivery), CHFO (Continuous High Frequency Oscillation; delivers aerosol with airway oscillation via positive pressure pulses), and CPEP (Continuous Positive Expiratory Pressure; delivers aerosol with continuous positive pressure to expand airways). Output: Medicated aerosol and pneumatic pressure pulses delivered to patient via disposable circuit (mouthpiece, mask, or ventilator interface). Used in hospitals, clinics, and sub-acute facilities by clinicians. Device assists in mobilizing secretions and resolving atelectasis; provides supplemental oxygen. Healthcare providers monitor pressure via integrated manometer and adjust modes/frequencies to optimize therapy.

Clinical Evidence

Bench testing only. Comparative performance testing included cascade impactor particle characterization (adult/pediatric flow rates), cleaning validation, simulated life cycle testing, and environmental/mechanical testing. Performance metrics compared peak pressures and respirable dose (Albuterol, Ipratropium, Cromolyn) across modes against predicates.

Technological Characteristics

Pneumatic system; fixed venturi patient circuit. Materials: Gas/fluid pathway components evaluated per ISO 10993-1 (cytotoxicity, sensitization, irritation, genotoxicity, implantation). Energy: 50 psi oxygen source. Modes: CPEP (static flow, ≤30 cmH2O), CHFO (up to 300 BPM, ≤30 cmH2O), Aerosol Only. Connectivity: Standalone pneumatic controller with manometer. Sterilization: Disposable patient circuit.

Indications for Use

Indicated for mobilization of secretions, lung expansion therapy, treatment and prevention of pulmonary atelectasis, and supplemental oxygen delivery. Patient population: Adults and children > 2 years old.

Regulatory Classification

Identification

A noncontinuous ventilator (intermittent positive pressure breathing-IPPB) is a device intended to deliver intermittently an aerosol to a patient's lungs or to assist a patient's breathing.

Predicate Devices

PowerNeb® CoMedica (K051964)
IPV - Percussionaire Corp (K895485)

Related Devices

K151689 — MetaNeb 4 System · Hill-Rom Services Pte, Ltd. · Mar 17, 2016
K051964 — POWERNEB · Comedica , Inc. · Dec 1, 2005
K231728 — BiWaze Clear System · Abmrc, LLC · Apr 8, 2024
K163091 — VibraPEP · Medica Holdings, LLC · Feb 21, 2017
K213564 — BiWaze Clear System · Abmrc, LLC · Dec 21, 2022

Submission Summary (Full Text)

{0}------------------------------------------------ K124032 510(k) Summary Page 1 of 8 | Date Prepared | 26-Mar-13 | APR 2 5 2013 | |-----------------------------------------------------------------------------|----------------------------------------------------------------------|--------------| | Hill-Rom Services Pte Ltd 1 Yishun Ave 7 Singapore, 768923, Singapore | Tel - 011 - 65 65945215 Fax - 011 - 65 65945201 | | | Official Contact: | Hejie Wang - RA / QA Specialist | | | Proprietary or Trade Name: | MetaNeb® or MetaNeb® 4 | | | Common/Usual Name: | Noncontinuous ventilator (IPPB) | | | Classification Code/Name: | NHJ - non-continuous ventilator (IPPB) 21 CFR 868.5905 Class 2 | | | Predicate Devices: | K051964 - PowerNeb® CoMedica K895485 - IPV - Percussionaire Corp | | #### Device Description: The MetaNeb® System is a therapeutic device that uses a systematic approach to enhance normal mucus clearance and resolve or prevent patchy atelectasis. The system has three modes: · - . Aerosol-for the delivery of aerosol only. In this mode CHFO and CPEP are not available. - CHFO (Continuous High Frequency Oscillation)-a pneumatic form of chest physiotherapy that delivers . medicated aerosol while oscillating the airways with continuous pulses of positive pressure. - CPEP (Continuous Positive Expiratory Pressure)-supplies medicated aerosol combined with continuous . positive pressure to help hold open and expand the airways. There are three maior components to The MetaNeb® System: - Circuit includes a mouthpiece, handset, nebulizer, tubing, and filter/tri-connector. It is a single patient . use, disposable that is intended for multiple treatment sessions. - Controller contains the controls to select the three different modes. It also has a manometer to monitor . pressure. Power is supplied by a hose connected to a 50 psi oxygen source. - Stand lets The MetaNeb® System be easily moved from room to room. . #### Indications for Use: The MetaNeb® System is indicated for mobilization of secretions, lung expansion therapy, the treatment and prevention of pulmonary atelectasis, and also has the ability to provide supplemental oxygen when used with compressed oxygen. #### Patient Population: Adult and Child > 2 years old {1}------------------------------------------------ #### 510(k) Summary Page 2 of 8 26-Mar-13 #### Environment of Use: Hospitals, sub-acute facilities, physician offices, and clinics. #### Predicate Device Comparison: The MetaNeb® system is viewed as substantially equivalent to the predicate devices because: #### Indications - The proposed indications for use for mobilization of secretions, lung expansion therapy, the treatment and prevention of pulmonary atelectasis, and also has the ability to provide supplemental oxygen when used with compressed oxygen are identical to the predicates Discussion: The indications for use are identical to the predicates CoMedica PowerNeb (K51964) and Bird IPV (K895485). #### Technology - The design of the MetaNeb® system as a pneumatically operated system with different modes of operation: CPEP. CHFO, and aerosol only are identical to the predicates in design and basic function and performance. Discussion: The design of MetaNeb® is substantially equivalent to the predicates CoMedica PowerNeb (K51964) and Bird IPV (K895485). The MetaNeb® offers some convenient features for the user that are different than the predicates. These are Aerosol Only mode vs. the Comedica PowerNeb (K051964) which requires the user to set the CPEP to minimum flow to deliver aerosol only. While the predicate IPV (K895485) has use an in-line nebulizer but does not have an aerosol only setting. These differences do not raise any new safety or efficacy concerns relative to the predicates. #### Materials - The materials in the gas and fluid pathway are considered external communicating, tissue contacting, prolonged duration have been tested per ISO 10993-1. Discussion: All associated materials in the gas or fluid pathway have been tested per ISO 10993-1 and where applicable VOC and PM2 & testing was performed. The results demonstrate the materials to be safe for the intended use. #### Environment of Use - The proposed environments of use are hospital and sub-acute facilities which are identical to the predicates, noting that the Bird IPV is also intended for the home environment. Discussion: The intended environments of use are identical to the predicates CoMedica PowerNeb (K.51964) and Bird IPV (K895485). {2}------------------------------------------------ ### 510(k) Summary Page 3 of 8 26-Mar-13 #### Patient Population - The MetaNeb® is intended for patients that require therapy mobilization of secretions, lung expansion therapy, the treatment and prevention of pulmonary atelectasis. Discussion: It is noted that the Bird IPV indicates that it is used with neonates to adults and the patient population for the MetaNeb® system could be > 2 years old. This is considered equivalent to the predicates CoMedica PowerNeb (K51964) and Bird IPV (K895485). #### Differences - There are no differences between the proposed device which would raise any new safety or risks and thus can be found to be substantially equivalent. | | MetaNeb® | PowerNeb CoMedica - K051964 | IPV Bird - K895485 | |-----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | CFR Classification | 868.5905 | 868.5905 | 868.5905 | | Classification name | NHJ | NHJ | NHJ | | | Device, positive pressure breathing, intermittent (IPPB) | Device, positive pressure breathing, intermittent (IPPB) | Device, positive pressure breathing, intermittent (IPPB) | | Indications for Use | Indicated for mobilization of secretions, lung expansion therapy, treatment and prevention of pulmonary atelectasis, ability to provide supplemental oxygen when used with compressed oxygen. | Indicated for mobilization of secretions, lung expansion therapy, treatment and prevention of pulmonary atelectasis, ability to provide supplemental oxygen when used with compressed oxygen. | Indicated for the mobilization and raising of endobronchial secretions, bronchodilation, reducing mucosal edema, resolution of diffuse patchy atelectasis in all patient populations. | | Environments of Use | Hospital, sub-acute facilities | Hospital, sub-acute facilities | Hospital, sub-acute facilities, homecare | | Patient Population | Adult Child > 2 years old | All patients that require therapy mobilization of secretions, lung expansion therapy, the treatment and prevention of pulmonary atelectasis | All patient populations | #### Table 1 - Substantial Equivalence Comparative Table {3}------------------------------------------------ # 510(k) Summary | | MetaNeb® | PowerNeb | IPV | |----------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | CoMedica - K051964 | Bird - K895485 | | Contraindications | -Untreated tension pneumothorax -Untrained or unskilled operator -History of pneumothorax -Pulmonary air leak -Recent pneumonectomy -Pulmonary hemorrhage -Myocardial infarction -Vomiting | -Untreated tension pneumothorax -Untrained or unskilled operator -History of pneumothorax -Pulmonary air leak -Recent pneumonectomy -Pulmonary hemorrhage -Myocardial infarction -Vomiting | -Untreated tension pneumothorax -Lack of adequate, skilled supervision | | Mode of Operation | Pneumatic system using a fixed venturi patient circuit combined with medicated aerosol to deliver continuous high frequency oscillation therapy at 2 pre-set frequencies and amplitude. | Pneumatic system using a fixed venturi patient circuit combined with medicated aerosol to deliver continuous high frequency oscillation therapy at 1 pre-set frequency and amplitude | Pneumatic system using a variable (sliding) venturi patient circuit combined with medicated aerosol to deliver continuous high frequency oscillation therapy at multiple user settable frequencies and amplitudes. | | | Can deliver continuous expiratory pressure (CPEP) combined with medicated aerosol. | Can deliver continuous expiratory pressure (CPEP) combined with medicated aerosol. | Equivalent CPEP function not available. | | Modes | CPEP CHFO Aerosol Only | CPEP CHFO Can allow in-line aerosol treatments | CHFO Can allow in-line aerosol treatments | | CPEP Continuous Positive Expiratory Pressure | Controlled static flow with positive pressures ≤ 30 cm H2O | Controlled static flow with positive pressures ≤ 20 cm H2O | No static flow mode | · {4}------------------------------------------------ ### 510(k) Summary Page 5 of 8 26-Mar-13 | | MetaNeb® | PowerNeb CoMedica - K051964 | IPV Bird - K895485 | |---------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------| | CHFO Continuous High Frequency Oscillations | Controlled continuous flow with frequencies up to 300 beats per minute and peak positive pressures $\le$ 30 cmH2O | Controlled continuous flow with frequencies up to 300 beats per minute and peak positive pressures $\le$ 30 cmH2O | Controlled Intrapulmonary Percussive Ventilation (IPV) frequencies up to 300 beats per minute and peak positive pressures $\le$ 80 cmH2O | | Aerosol Only | Controlled continuous constant flow to in-line nebulizer delivering medicated aerosol only. | Equivalent Aerosol Only function by setting CPEP to minimum flow with in-line nebulizer | Can use in-line nebulizer | | Patient Circuit | Disposable circuit referred to as "hand-set" includes connection for in-line nebulizer | Disposable circuit referred to as "hand-set" includes connection for in-line nebulizer | Reusable circuit includes connection for in-line nebulizer | | | Draw in room air mix with medicated aerosol and gas from controller | Draw in room air mix with medicated aerosol and gas from controller | Draw in room air mix with medicated aerosol and gas from controller | | Patient Circuit settings | Expiratory resistance adjustment | Expiratory resistance adjustment | Not available | | Patient Interface | Mouthpiece Face mask Insert into ventilator circuit | Mouthpiece Face mask | Mouthpiece Insert into ventilator circuit | | Controller | Pneumatic and air or oxygen | Pneumatic and air or oxygen | Pneumatic and air or oxygen | | Controller settings | On/off Mode selection Frequency selection for CHFO mode Pressure adjustment for CPEP mode Pressure manometer Connection for patient circuit | On/off Mode selection Pressure adjustment for CPEP mode Connection for patient circuit | On/off Pressure and frequency adjustment for CHFO mode Pressure manometer Connection for patient circuit | | | MetaNeb® | PowerNeb CoMedica - K051964 | IPV Bird - K895485 | | Ventilator connection | Placed in-line in the inspiratory limb of the ventilator circuit with a standard "T" adapter. Ventilator set to pressure mode only | Not available | Placed in-line in the ventilator circuit with a IPV cone adapter Ventilator set to pressure mode only | | Performance Testing | | | | | CPEP Mode @ Max Flow Peak Pressure (cmH2O): Total Respirable Dose (0.5-5 um) (Report 12-0058) | 27.8 to 29.9 Albuterol 735.5 - 890.6 Ipratrompium 149.2 - 187 Cromolyn 2567.6 - 3046.6 | 32.6 to 35.1 Albuterol 631.5 - 818.8 Ipratrompium 137.1 - 155.1 Cromolyn 2362.1 - 2695.2 | This mode is not available on IPV | | CHFO Mode @ MetaNeb "High" Peak Pressure (cmH2O): Frequency (BPM) Total Respirable Dose (0.5-5 um) (Report 12-0058) | 21.1 to 25.4 226 Albuterol 139.2 - 200.2 Ipratrompium 27- 54.6 Cromolyn 673.1 - 948.1 Albuterol 421.6 - 572.4 Ipratrompium 124.5 - 204.6 Cromolyn 1367.9 - 1903.9 | 9.7 to 10.3 222 to 235 Albuterol 171.3 - 202.1 Ipratrompium 30.5 - 48.3 Cromolyn 805.4 - 1002.7 | 25.3 to 27.0 214 to 235 Albuterol 243.7 - 349.5 Ipratrompium 90 - 112.7 Cromolyn 900.1 - 1196.1 | | CHFO Mode @ MetaNeb "High" with Ventilator Connection Peak Pressure (cmH2O): Frequency (BPM) Total Respirable Dose (0.5-5 um) (Report 12-0061) | 20.5 to 44.1 226 to 231 Albuterol 95.8 + 13.1 Ipratrompium 110.8 + 8.6 Cromolyn 73.4 + 15.4 | | 19.8 to 44.4 226 to 235 Albuterol 91.1 + 10.6 Ipratrompium 97.1 ± 3.4 Cromolyn 88 + 9.2 | | | MetaNeb® | PowerNeb Comedica - K051964 | IPV Bird - K895485 | | Materials | Materials have been evaluated under the following Direct contact Indirect contact gas pathway VOC PM2.5 CO Ozone | Many materials are identical to the MetaNeb® Cleared under K051964 | No data - Cleared under K895485 | : . r . . ・ · - : · · : {5}------------------------------------------------ # 510(k) Summary · . + . · {6}------------------------------------------------ #### 510(k) Summary Page 7 of 8 26-Mar-13 #### Non-clinical Testing Summary - We performed comparative a series of non-clinical bench testing to demonstrate that the MetaNeb® is equivalent to the predicates. These tests included: - Comparative Particle Characterization testing via Cascade Impactor . - o Adult flow rates - Pediatric flow rates o - o In various controller modes (Aerosol, CHFO, CPEP) - . Cleaning validation - Simulated Life Cycle testing ' . - Environmental and Mechanical testing ● - . Comparative Performance Testing as compared to the predicate in simulated breathing and ventilator condition The other tests can be found in the identified Sections of this submission. - . Cleaning validation - . Environmental and Mechanical testing The comparative testing demonstrates that the proposed device is substantially equivalent to the predicate devices. #### Biocompatibility of Materials - · The MetaNeb® system has been evaluated for biocompatibility. There are several levels of patient contact and methods of testing that had to be utilized. The following is a summary of the system and our approach to evaluating biocompatibility. The system can be viewed as having 3 levels of biocompatibility: {7}------------------------------------------------ - Controller, which is a pneumatic system . - Address via VOC, CO, Ozone and PM25 testing . O - . Patient circuit before the nebulizer (Group 2 reference) - Indirect, external communicating, tissue / mucosal, prolonged duration (> 24 hr < 30 days) o - Cytotoxicity, Sensitization, Irritation / Intracutaneous reactivity o - Patient circuit components and materials after the nebulizer (Group 1) . - Indirect, external communicating, tissue / mucosal, permanent duration (> 30 days) per FDA o internal memo and historical guidance - Cytotoxicity, Sensitization, Genotoxicity, Implantation o #### Discussion - All materials were tested according to ISO 10993-1 for the appropriate level of patient contact and duration and found to pass the applicable ISO 10993-1 test requirements. #### Substantial Equivalence Conclusion - The sponsor has demonstrated through performance testing, design and features, and non-clinical testing that the proposed device and predicate have been found to substantially equivalent. {8}------------------------------------------------ #### DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/8/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged in a circular fashion around the symbol. The caduceus is depicted with three wavy lines, representing the snakes, and the text is in a simple, sans-serif font. #### Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 April 25, 2013 Mr. Paul Dryden Consultant Hill-Rom Services Pte, Limited 1-Yishun-Avenue-7 Singapore 768923 Re: K124032 Trade/Device Name: MetaNeb® Regulation Number: 21 CFR 868.5905 Regulation Name: Noncontinuous Ventilator (IPPB) Regulatory Class: II Product Code: NHJ Dated: March 26, 2013 Received: March 27, 2013 Dear Ms. Wang: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {9}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation.control.provisions.(Sections.531-542.of the Act); 21-CFR.1000=1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours. Kwame O. Ulmer-S for Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {10}------------------------------------------------ ## Indications for Use Statement . . . . . Page 1 of 1 | 510(k) Number: | K124032 | |----------------------|----------| | Device Name: | MetaNeb® | | Indications for Use: | | The MetaNeb® System is indicated for mobilization of secretions, lung expansion therapy, the treatment and prevention of pulmonary atelectasis, and also has the ability to provide supplemental oxygen when used with compressed oxygen. Patient population - Adult and Children > 2 years old Environments of use - Hospitals, sub-acute facilities, physician offices, and clinics. | Prescription Use XX (Part 21 CFR 801 Subpart D) | or | Over-the-counter use (21 CFR 807 Subpart C) | |-------------------------------------------------|----|---------------------------------------------| |-------------------------------------------------|----|---------------------------------------------| (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Amy K-Levelle, S 2013.04.25 10:34:25 for L.S. -04'00' (Division Sign-Off) Division of Anesthesiology, General Hospital eneral Hospital Division of Anesthestology, Gental Devices **510(k) Number:** K124032 Page 28 of 311

METANEB

Device Facts

Intended Use

Device Story

Clinical Evidence

Technological Characteristics

Indications for Use

Regulatory Classification

Identification

Predicate Devices

Related Devices

Submission Summary (Full Text)

Panel 1

Section Matches

Product Code Matches

Special Control Matches

My Alerts

METANEB

Device Facts

Intended Use

Device Story

Clinical Evidence

Technological Characteristics

Indications for Use

Regulatory Classification

Identification

Predicate Devices

Related Devices

Submission Summary (Full Text)

Panel 1

Section Matches

Product Code Matches

Special Control Matches

My Alerts

Create Alert

Search Filters

Agent Token

Welcome

Check your email

Welcome!